Bangladeshi drugmaker Beximco Pharmaceuticals, a specialist in the production of generic medications and active pharmaceutical ingredients, says that it has begun exporting drugs to Belize in Central America. The firm explained that the first shipment contained supplies of 25 different products, including antibacterials, antihypertensives, lipid lowering drugs, pain relivers, respiratory treatments and antihistamines.
The company, which already sells pharmaceuticals to a number of countries in East Africa and South East Asia, said that the move was part of its global growth strategy. Nazmul Hassan, the firm's chief executive, explained that entering the Central and South American market was a step towards gaining a foothold in "highly regulated countries."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze